cancer drug development – Discover Pharma

Welcome to Discover Pharma! Today is : October 11, 2026

cancer drug development

Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Sapience Therapeutics gets FDA clearance for ST316 FAP study
The FDA has cleared Sapience Therapeutics to begin clinical development [...]

September 16, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA grants Fast Track designation to Erasca pancreatic cancer drug
The FDA has granted Fast Track designation to Erasca’s investigational [...]

August 24, 2026
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
The US FDA has granted Fast Track Designation to SOTIO [...]

July 14, 2026
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
Faeth Therapeutics focuses on PIKTOR as oncology Phase 2 data nears
Faeth Therapeutics has launched as a publicly traded oncology company [...]

June 16, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK